These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1299 related items for PubMed ID: 28530155

  • 1. An Oncolytic Adenovirus Encoding Decorin and Granulocyte Macrophage Colony Stimulating Factor Inhibits Tumor Growth in a Colorectal Tumor Model by Targeting Pro-Tumorigenic Signals and via Immune Activation.
    Liu Z, Yang Y, Zhang X, Wang H, Xu W, Wang H, Xiao F, Bai Z, Yao H, Ma X, Jin L, Wu C, Seth P, Zhang Z, Wang L.
    Hum Gene Ther; 2017 Aug; 28(8):667-680. PubMed ID: 28530155
    [Abstract] [Full Text] [Related]

  • 2. Oncolytic Adenovirus rAd.DCN Inhibits Breast Tumor Growth and Lung Metastasis in an Immune-Competent Orthotopic Xenograft Model.
    Zhao H, Wang H, Kong F, Xu W, Wang T, Xiao F, Wang L, Huang D, Seth P, Yang Y, Wang H.
    Hum Gene Ther; 2019 Feb; 30(2):197-210. PubMed ID: 30032645
    [Abstract] [Full Text] [Related]

  • 3. An Oncolytic Adenovirus Targeting Transforming Growth Factor β Inhibits Protumorigenic Signals and Produces Immune Activation: A Novel Approach to Enhance Anti-PD-1 and Anti-CTLA-4 Therapy.
    Yang Y, Xu W, Peng D, Wang H, Zhang X, Wang H, Xiao F, Zhu Y, Ji Y, Gulukota K, Helseth DL, Mangold KA, Sullivan M, Kaul K, Wang E, Prabhakar BS, Li J, Wu X, Wang L, Seth P.
    Hum Gene Ther; 2019 Sep; 30(9):1117-1132. PubMed ID: 31126191
    [Abstract] [Full Text] [Related]

  • 4. Oncolytic adenovirus encoding decorin and CD40 ligand inhibits tumor growth and liver metastasis via immune activation in murine colorectal tumor model.
    Rong Y, Ning Y, Zhu J, Feng P, Zhu W, Zhao X, Xiong Z, Ruan C, Jin J, Wang H, Cai T, Zhang S, Yang Y.
    Mol Biomed; 2024 Sep 22; 5(1):39. PubMed ID: 39306655
    [Abstract] [Full Text] [Related]

  • 5. Tumor-specific oncolytic adenoviruses expressing granulocyte macrophage colony-stimulating factor or anti-CTLA4 antibody for the treatment of cancers.
    Du T, Shi G, Li YM, Zhang JF, Tian HW, Wei YQ, Deng H, Yu DC.
    Cancer Gene Ther; 2014 Aug 22; 21(8):340-8. PubMed ID: 25034886
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Oncolytic adenovirus coexpressing interleukin-12 and decorin overcomes Treg-mediated immunosuppression inducing potent antitumor effects in a weakly immunogenic tumor model.
    Oh E, Choi IK, Hong J, Yun CO.
    Oncotarget; 2017 Jan 17; 8(3):4730-4746. PubMed ID: 28002796
    [Abstract] [Full Text] [Related]

  • 8. A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes.
    Hu ZB, Wu CT, Wang H, Zhang QW, Wang L, Wang RL, Lu ZZ, Wang LS.
    Cancer Gene Ther; 2008 Mar 17; 15(3):173-82. PubMed ID: 18157145
    [Abstract] [Full Text] [Related]

  • 9. Oncolytic Activity of a Novel Influenza A Virus Carrying Granulocyte-Macrophage Colony-Stimulating Factor in Hepatocellular Carcinoma.
    Penghui Y, Fang S, Ruilan W, Guanglin L, Hongjing G, Yueqiang D, Zhongpeng Z, Xiaolan Y, Zhaohai W, Shaogeng Z, Xiliang W.
    Hum Gene Ther; 2019 Mar 17; 30(3):330-338. PubMed ID: 30205709
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Local Delivery of OncoVEXmGM-CSF Generates Systemic Antitumor Immune Responses Enhanced by Cytotoxic T-Lymphocyte-Associated Protein Blockade.
    Moesta AK, Cooke K, Piasecki J, Mitchell P, Rottman JB, Fitzgerald K, Zhan J, Yang B, Le T, Belmontes B, Ikotun OF, Merriam K, Glaus C, Ganley K, Cordover DH, Boden AM, Ponce R, Beers C, Beltran PJ.
    Clin Cancer Res; 2017 Oct 15; 23(20):6190-6202. PubMed ID: 28706012
    [Abstract] [Full Text] [Related]

  • 15. Linked tumor-selective virus replication and transgene expression from E3-containing oncolytic adenoviruses.
    Zhu M, Bristol JA, Xie Y, Mina M, Ji H, Forry-Schaudies S, Ennist DL.
    J Virol; 2005 May 15; 79(9):5455-65. PubMed ID: 15827160
    [Abstract] [Full Text] [Related]

  • 16. Arming oncolytic reovirus with GM-CSF gene to enhance immunity.
    Kemp V, van den Wollenberg DJM, Camps MGM, van Hall T, Kinderman P, Pronk-van Montfoort N, Hoeben RC.
    Cancer Gene Ther; 2019 Sep 15; 26(9-10):268-281. PubMed ID: 30467340
    [Abstract] [Full Text] [Related]

  • 17. Oncolytic virotherapy with an HSV amplicon vector expressing granulocyte-macrophage colony-stimulating factor using the replication-competent HSV type 1 mutant HF10 as a helper virus.
    Kohno SI, Luo C, Nawa A, Fujimoto Y, Watanabe D, Goshima F, Tsurumi T, Nishiyama Y.
    Cancer Gene Ther; 2007 Nov 15; 14(11):918-26. PubMed ID: 17693992
    [Abstract] [Full Text] [Related]

  • 18. Strengthening of antitumor immune memory and prevention of thymic atrophy mediated by adenovirus expressing IL-12 and GM-CSF.
    Choi KJ, Zhang SN, Choi IK, Kim JS, Yun CO.
    Gene Ther; 2012 Jul 15; 19(7):711-23. PubMed ID: 21993173
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prime-boost immunization by both DNA vaccine and oncolytic adenovirus expressing GM-CSF and shRNA of TGF-β2 induces anti-tumor immune activation.
    Kim SY, Kang D, Choi HJ, Joo Y, Kim JH, Song JJ.
    Oncotarget; 2017 Feb 28; 8(9):15858-15877. PubMed ID: 28178658
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 65.